Ropes & Gray Advised Pfizer in $61 Million Financing Round for Vibrant Therapeutics

Ropes & Gray Advised Pfizer in $61 Million Financing Round for Vibrant Therapeutics

Ropes & Gray represented Pfizer Ventures in its investment in Vibrant Therapeutics, a clinical-stage biotechnology company developing next-generation intelligent therapeutics. The $61 million financing round includes new investors Pfizer Ventures and Apricot Capital with participation from Bayland Capital, HSG, Northern Light Venture Capital and First Principle Venture Limited, and brings Vibrant’s total capital raised to $100 million.

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances.

The Ropes & Grey team was led by Brad Flint (Partner/ Emerging Companies & Venture Capital) and Alyce Chen (Associate) and Joe Muller (Associate).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.